BUSINESSSTAT NEWS
STAT+: Eli Lilly dives into hair loss treatments with investment in AI startup Absci
Eli Lilly is investing $40 million in Absci, an AI startup developing treatments for hair loss and endometriosis. Absci raised $100 million in total funding led by Eli Lilly, with the startup publicly traded on Nasdaq.
Related Signal
Adjacent reporting
- STAT+: Gene-editing startup launches with $230 million and a Chinese licensing deal
- Robotics startup Generalist AI is raising $400 million at a $2 billion valuation
- STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
- Musely secures $360M from General Catalyst without giving up equity